>
In 1990 the FDA banned Red Dye 3 from lipstick in 1990
How to fight back against the surveillance state
The Truth About Soil Health (And Why It Changes Everything)
Heads up: Apparently the government is hiding cameras inside fake utility boxes
Sodium Batteries And EVs That Power The Grid: Inside GM's Big Energy Push
NUCLEAR ENGINE - UNLIMITED LUXURY - 20 YEARS WITHOUT REFUELING
China Unveils Nuclear-Powered Floating Hub For Green Shipping
China Launches World's 1st Commercial Brain Chip, Beating Elon Musk's Neuralink!
Modular next-gen US nuclear reactor goes critical
This Company Will Add Phone, AirPod, and Smartwatch Trackers to License Plate Readers
Elon Details SpaceX AI Data Center in Space Details and Roadmap

With promising early results, the researchers say their findings could usher in trials where such transplantations are put to the test in humans.
Stem cells have shown exciting potential in improving the vision of patients with degenerative eye disorders for years. In 2010, scientists reported the creation of the first early-stage retina engineered with human embryonic stem cells. Then in 2012, two legally blind patients experienced improvements to their vision after receiving transplants of retinal cells, also derived from human embryonic stem cells.
But what sets this latest achievement apart is that scientists from Osaka and Cardiff University's were able to use human stem cells to reproduce something closer to the complex nature of the entire eyeball. Using induced pluripotent stem cells, or cells derived directly from adult cells, they were able to cultivate multiple cell lineages of the eye, including the lens, cornea and conjunctiva.